This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.
Clinical and experimental immunology, 191(1), 96-106
Citation
Kusaka, S; Nishida, A; Takahashi, K; Bamba, S; Yasui, H; Kawahara, M; Inatomi, O; Sugimoto, M; Andoh, A. (2018). Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.. Clinical and experimental immunology, 191(1), 96-106. https://doi.org/10.1111/cei.13047